LENZ Therapeutics, Inc. (NASDAQ: LENZ) reported Q1 EPS of ($1.32). Revenue for the quarter came in at $1.9 million.

For earnings history and earnings-related data on LENZ Therapeutics, Inc. (LENZ) click here.